Ownership and insider activity for CAMP4 Therapeutics Corporation (CAMP): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Price
| Price | $3.86 |
| Market Cap | $82M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93.7M | $132.6M | $256.5M | $107.4M | $91.7M | $91.1M | $83.2M | $38.4M | $64.0M | $109.5M |
| Short-term Investments | $6.7M | $23.4M | $17.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $67.4M | $71.6M | $78.1M | $72.3M | $67.9M | $58.6M | $678000 | $442000 | $108000 | $155000 |
| Inventory | $29.3M | $36.3M | $32.0M | $36.8M | $32.2M | $20.2M | 0 | 0 | 0 | 0 |
| Total Current Assets | $206.7M | $275.9M | $403.5M | $237.9M | $215.2M | $193.6M | $84.4M | $40.0M | $66.4M | $114.1M |
| Property, Plant & Equipment | $21.2M | $21.3M | $27.0M | $76.5M | $62.2M | $50.1M | $16.8M | $13.3M | $10.3M | $2.7M |
| Goodwill | $73.0M | $73.0M | $80.8M | $106.3M | $94.5M | $94.0M | 0 | 0 | 0 | 0 |
| Intangible Assets | $67.2M | $52.5M | $47.2M | $45.9M | $38.9M | $33.0M | 0 | 0 | 0 | 0 |
| Total Assets | $407.7M | $473.0M | $603.6M | $495.8M | $441.8M | $402.3M | $102.5M | $54.9M | $78.3M | $117.8M |
| Accounts Payable | $30.3M | $35.5M | $39.9M | $28.4M | $36.8M | $30.8M | $2.2M | $1.0M | $1.2M | $182000 |
| Short-term Debt | $11.0M | $32.2M | $36.8M | $37.8M | $10.9M | $7.7M | 0 | 0 | 0 | $286000 |
| Total Current Liabilities | $76.6M | $95.5M | $83.6M | $121.5M | $107.4M | $94.9M | $7.9M | $7.8M | $9.6M | $15.5M |
| Long-term Debt | $146.8M | $154.3M | $275.9M | $201.4M | $199.9M | $201.4M | 0 | 0 | 0 | $1.7M |
| Total Liabilities | $243.7M | $274.1M | $398.0M | $357.9M | $342.5M | $322.1M | $180.1M | $178.7M | $15.2M | $70.1M |
| Retained Earnings | -$47.0M | -$19.5M | -$2.2M | -$81.5M | -$129.2M | -$156.8M | -$110.7M | -$160.0M | -$211.8M | -$292.2M |
| Total Equity | $164.0M | $198.9M | $205.7M | $137.9M | $99.3M | $80.2M | -$77.5M | -$123.7M | $63.1M | $47.7M |
| Total Debt | $146.8M | $154.3M | $275.9M | $234.5M | $210.8M | $209.2M | $12.4M | $11.7M | $8.6M | $2.0M |
| Net Debt | $46.4M | -$1.7M | $1.9M | $127.1M | $119.1M | $118.1M | -$70.8M | -$26.7M | -$55.4M | -$107.5M |
| Working Capital | $130.1M | $180.4M | $319.9M | $116.4M | $107.8M | $98.7M | $76.5M | $32.2M | $56.8M | $98.6M |
Financial Health
| Debt / Equity | -3.42 |
| Current Ratio | 4.70 |
Profitability
| Return on Equity | -314.08% |
| Return on Invested Capital | -69.76% |
| Return on Assets | -114.79% |
| Gross Margin | 77.80% |
| Operating Margin | -1242.50% |
| Net Margin | -2543.74% |
Related companies: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explore sector: Healthcare · Biotechnology
More sections of CAMP: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks